In particular, there is a growing amount of evidence that associates APE1 overexpression with the development of several types of cancers, including lung [17], colon [95], liver [96], prostate [97], ovarian [98], and bladder cancer [99]. Here, APEX1 is linked to urinary bladder cancer.